AstraZeneca
pipeline success leads to multiple launches of differentiated medicines i i first and only self auto injector for the treatment of first and only rescue inhaler that also reduces risk of asthma exacerbations first and only approved for the broad infant population | AstraZeneca
Company
Deck Type
Deck date
February 2024
Slide
21 of 45
Other recent decks by AstraZeneca
Investor Conference
January 2024
Results
November 2023
Results
July 2023
Investor Event
June 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io